Axsome Therapeutics Inc (AXSM): Next-Year EPS Estimate 394.56%
As of 2026-05-20, Axsome Therapeutics Inc (AXSM) has a next-year EPS growth estimate of 394.56%. Featured in our EPS revision report on 2026-05-04.
On 2026-05-10, analyst consensus for AXSM's next-year EPS growth shifted from 389.95% to 394.56% — a positive change of 4.61 percentage points. The revised estimate has been sustained across 9 subsequent trading sessions. Current-year growth is projected at 46.68%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 394.56%
- EPS growth this year
- 46.68%
- EPS next quarter (est)
- -$0.84
- Last price
- $230.62
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-20 | 394.56% | 46.68% | -$0.84 | $230.62 |
| 2026-05-19 | 394.56% | 46.68% | -$0.84 | $226.67 |
| 2026-05-18 | 394.56% | 46.68% | -$0.84 | $227.40 |
| 2026-05-17 | 394.56% | 46.68% | -$0.84 | $227.72 |
| 2026-05-14 | 394.56% | 46.68% | -$0.84 | $232.27 |
| 2026-05-13 | 394.56% | 46.68% | -$0.84 | $233.98 |
| 2026-05-12 | 394.56% | 46.68% | -$0.84 | $224.03 |
| 2026-05-11 | 394.56% | 46.68% | -$0.84 | $216.47 |
| 2026-05-10 | 394.56% | 46.68% | -$0.84 | $217.38 |
| 2026-05-07 | 389.95% | 46.74% | -$0.85 | $220.22 |
| 2026-05-06 | 390.02% | 46.75% | -$0.85 | $222.63 |
| 2026-05-05 | 390.02% | 46.75% | -$0.85 | $223.06 |
| 2026-05-04 | 676.30% | 70.68% | -$0.59 | $223.70 |
| 2026-05-03 | 968.17% | 79.95% | -$0.81 | $206.53 |
| 2026-04-30 | 840.43% | 77.23% | -$0.84 | $207.75 |
| 2026-04-29 | 840.26% | 77.23% | -$0.84 | $183.95 |
| 2026-04-28 | 755.61% | 74.63% | -$0.86 | $185.00 |
| 2026-04-27 | 763.60% | 74.93% | -$0.84 | $187.40 |
| 2026-04-26 | 763.60% | 74.93% | -$0.84 | $185.96 |
| 2026-04-24 | 763.60% | 74.93% | -$0.84 | $185.96 |
| 2026-04-23 | 824.17% | 76.56% | -$0.83 | $182.72 |
| 2026-04-22 | 824.17% | 76.56% | -$0.83 | $186.42 |
| 2026-04-21 | 813.19% | 76.18% | -$0.83 | $182.97 |
| 2026-04-20 | 815.87% | 76.32% | -$0.83 | $188.69 |
| 2026-04-19 | 815.87% | 76.32% | -$0.83 | $188.99 |
| 2026-04-16 | 815.87% | 76.32% | -$0.83 | $184.19 |
| 2026-04-15 | 815.87% | 76.32% | -$0.83 | $184.18 |
| 2026-04-14 | 815.70% | 76.32% | -$0.83 | $184.18 |
| 2026-04-13 | 815.70% | 76.32% | -$0.83 | $178.33 |
| 2026-04-12 | 866.18% | 77.62% | -$0.82 | $178.11 |
Reports Featuring AXSM
Recent News
- Axsome Therapeutics, Inc. Q1 2026 Earnings Call SummaryMoby
- Axsome: Q1 Earnings SnapshotAssociated Press
- Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswire
- Summits self-inflicted stumble; Esperions take-private dealBioPharma Dive
- Summits self-inflicted stumble; Esperions take-private dealBioPharma Dive
- Axsome Therapeutics Hosts AUVELITY FDA Approval Investor Event Featuring Expert Thought LeaderGlobeNewswire
- Axsome Therapeutics Hosts AUVELITY FDA Approval Investor Event Featuring Expert Thought LeaderGlobeNewswire
- Axsome Therapeutics Announces FDA Approval of AUVELITY (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer's DiseaseGlobeNewswire
- Biotech Stock Knocks At $2 Billion Opportunity, Nears Buy PointInvestor's Business Daily
Screen Performance
Aggregate stats across all 1713 tickers our top-EPS-revision screen has flagged over the past 49 days.
- Median return since detection
- +2.8%
- % of tickers in the green
- 58%
- Median return on winners
- +15.1%
- Large revisions captured
- 630
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Axsome Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-05-20, Axsome Therapeutics Inc (AXSM) has a next-year EPS growth estimate of 394.56%, based on analyst consensus.
When was the latest EPS estimate revision for AXSM?▾
The most recent revision occurred on 2026-05-10, when analysts adjusted the next-year EPS growth estimate from 389.95% to 394.56%.
What sector and industry does Axsome Therapeutics Inc belong to?▾
Axsome Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AXSM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Axsome Therapeutics Inc (AXSM) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports